Tolerance & Responsiveness Improvement for Metformin (TRIM)

NCT03670043 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes Mellitus

Interventions

DRUG: Psyllium powder
DRUG: Metformin Extended Release Oral Tablet

Sponsor

West Side Institute for Science and Education